Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: Results from two clinical trials

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 8, 2012, Pages

  Agrawal, Ashish ^a   Zhuo, Hanjing ^a   Brady, Sandra ^a   Levitt, Joseph ^b   Steingrub, Jay ^c   Siegel, Mark D ^d   Soto, Graciela ^e   Peterson, Michael W ^f   Chesnutt, Mark S ^g   Matthay, Michael A ^a   Liu, Kathleen D ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

^d YALE UNIVERSITY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g PORTLAND VA MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute respiratory distress syndrome; Bronchoalveolar lavage; Interleukin 6; Pulmonary edema; Respiratory failure

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 8; THROMBOMODULIN;

ACUTE LUNG INJURY; ADULT; APACHE; ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OXYGENATION; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL;

ACUTE LUNG INJURY; ADULT; AGED; APACHE; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROTEIN C; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOMODULIN;

EID: 84867737911     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00195.2012     Document Type: Article

References (29)

1. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury, and the acute respiratory distress syndrome. N Engl J Med 342: 1301-1308, 2000.
2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
3. Brower R, Lanken P, MacIntyre N, Matthay M, Morris A, Ancukie-wicz M, Schoenfeld D, Thompson B; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network.Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351: 327-336, 2004.
4. Calfee CS, Budev MM, Matthay MA, Church G, Brady S, Uchida T, Ishizaka A, Lara A, Ranes JL, deCamp MM, Arroliga AC. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transplant 26: 675-680, 2007.
5. Calfee CS, Eisner MD, Ware LB, Thompson BT, Parsons PE, Wheeler AP, Korpak A, Matthay MA. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 35: 2243-2250, 2007.
6. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wick-ersham N, Matthay MA. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63: 1083-1089, 2008.
7. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III Procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 122: 17-23, 1995.
8. Eisner M, Parsons P, Matthay M, Ware L, Greene K, Acute Respiratory Distress Syndrome Network. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 58: 983-988, 2003.
9. Fremont RD, Koyama T, Calfee CS, Wu W, Dossett LA, Bossert FR, Mitchell D, Wickersham N, Bernard GR, Matthay MA, May AK, Ware LB. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 68: 1121-1127, 2010.
10. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 178: 618-623, 2008.
11. Matthay MA. Fibrosing alveolitis in the adult respiratory distress syndrome. Ann Intern Med 122: 65-66, 1995.
12. Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, Holets S, Kallet RH, Liu KD, Macintyre N, Moss M, Schoenfeld D, Steingrub J, Thompson BT. Randomized, placebo-controlled clinical trial of an aerosolized beta-2 agonist for treatment of acute lung injury. Am J Respir Crit Care Med 184: 561-568, 2011.
13. McClintock D, Zhuo H, Wickersham N, Matthay MA, Ware LB. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care 12: R41, 2008.
14. Ortiz RM, Cilley RE, Bartlett RH. Extracorporeal membrane oxygen-ation in pediatric respiratory failure. Pediatr Clin North Am 34: 39-46, 1987.
15. Parsons P, Eisner M, Thompson B, Matthay M, Ancukiewicz M, Bernard G, Wheeler A, NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 33: 1-6, 2005.
16. Pittet JF, Wiener-Kronish JP, Serikov V, Matthay MA. Resistance of the alveolar epithelium to injury from septic shock in sheep. Am J Respir Crit Care Med 151: 1093-1100, 1995.
17. Prabhakaran P, Ware L, White K, Cross M, Matthay M, Olman M. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285: L20-L28, 2003.
18. Rice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxi-dant supplementation in acute lung injury. JAMA 306: 1574-1581, 2011.
19. Rice TW, Wheeler AP, Thompson BT, Steingrub J, Hite RD, Moss M, Morris A, Dong N, Rock P. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 307: 795-803, 2012.
20. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005.
21. Seeley E, McAuley DF, Eisner M, Miletin M, Matthay MA, Kallet RH. Predictors of mortality in acute lung injury during the era of lung protective ventilation. Thorax 63: 994-998, 2008.
22. Ware LB, Conner ER, Matthay MA. Von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 29: 2325-2331, 2001.
23. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 170: 766-772, 2004.
24. Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 285: L514-L521, 2003.
25. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137: 288-296, 2010.
26. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
27. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 35: 1821-1828, 2007.
28. Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, Wiedemann HP, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354: 2213-2224, 2006.
29. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354: 2564-2575, 2006.